EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Morio, Yoshiteru ^a   Carter, Ethan P ^a   Oka, Masahiko ^a   McMurtry, Ivan F ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytochrome P 450; Endothelium derived hyperpolarizing factor; Gap junctions; Hypoxia; Pulmonary hypertension; Pulmonary vasoregulation

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; APAMIN; CHARYBDOTOXIN; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ETHOXYRESORUFIN; NITRIC OXIDE SYNTHASE; PALMITOLEIC ACID; PROSTAGLANDIN SYNTHASE; SULFAPHENAZOLE; THAPSIGARGIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GAP JUNCTION; HYPERTENSION; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0037405055     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00831.2002     Document Type: Article

References (59)

1. Adeagbo AS. Endothelium-derived hyperpolarizing factor: characterization as a cytochrome P450 1A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. Am J Hypertens 10: 763-771, 1997.
2. Bagate K, Grima M, Imbs JL, Jong WD, Helwig JJ, and Barthelmebs M. Signal transduction pathways involved in kinin B(2) receptor-mediated vasodilation in the rat isolated perfused kidney. Br J Pharmacol 132: 1735-1742, 2001.
3. Beny JL and Schaad O. An evaluation of potassium ions as endothelium-derived hyperpolarizing factor in porcine coronary arteries. Br J Pharmacol 131: 965-973, 2000.
4. Bonnet S, Hyvelin JM, Bonnet P, Marthan R, and Savineau JP. Chronic hypoxia-induced spontaneous and rhythmic contractions in the rat main pulmonary artery. Am J Physiol Lung Cell Mol Physiol 281: L183-L192, 2001.
5. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
6. Campbell WB and Harder DR. Prologue: EDHF-what is it? Am J Physiol Heart Circ Physiol 280: H2413-H2416, 2001.
7. Ca channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 279: L903-L910, 2000.
8. Chang SW, Dutton D, Wang HL, He LS, Stearns R, Hui A, Giacomini KM, Ortiz de Montellano P, and Voelkel NF. Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 263: L446-L453, 1992.
9. Chaytor AT, Evans WH, and Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol 508: 561-573, 1998.
10. Chaytor AT, Marsh WL, Hutcheson IR, and Griffith TM. Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium 7: 265-278, 2000.
11. Chen G and Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. J Physiol 410: 91-106, 1989.
12. + currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J Physiol 531: 359-373, 2001.
13. Domenighetti AA, Beny JL, Chabaud F, and Frieden M. An intercellular regenerative calcium wave in porcine coronary artery endothelial cells in primary culture. J Physiol 513: 103-116, 1998.
14. Dong H, Jiang Y, Cole WC, and Triggle CR. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels. Br J Pharmacol 130: 1983-1991, 2000.
15. Dora KA. Cell-cell communication in the vessel wall. Vasc Med 6: 43-50, 2001.
16. Doughty JM, Boyle JP, and Langton PD. Potassium does not mimic EDHF in rat mesenteric arteries. Br J Pharmacol 130: 1174-1182, 2000.
17. Doughty JM, Plane F, and Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am J Physiol Heart Circ Physiol 276: H1107-H1112, 1999.
18. +. Br J Pharmacol 129: 811-819, 2000.
19. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
20. Feletou M and Vanhoutte PM. Endothelium-dependent hyperpolarization of vascular smooth muscle cells. Acta Pharmacol Sin 21: 1-18, 2000.
21. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
22. Fleming I. Cytochrome P450 and vascular homeostasis. Circ Res 89: 753-762, 2001.
23. + channel blockers and cytochrome P450 inhibitors on acetylcholine-induced, endothelium-dependent relaxation in rabbit mesenteric artery. Eur J Pharmacol 384: 7-15, 1999.
24. Fukao M, Hattori Y, Kanno M, Sakuma I, and Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br J Pharmacol 120: 439-446, 1997.
25. ATP channels. Br J Pharmacol 121: 271-279, 1997.
26. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, and Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
27. +-relaxation. Eur J Pharmacol 402: 119-128, 2000.
28. Hasunuma K, Yamaguchi T, Rodman DM, O'Brien RF, and McMurtry IF. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am J Physiol Lung Cell Mol Physiol 260: L97-L104, 1991.
29. Hill CE, Hickey H, and Sandow SL. Role of gap junctions in acetylcholine-induced vasodilation of proximal and distal arteries of the rat mesentery. J Auton Nerv Syst 81: 122-127, 2000.
30. Hill CE, Phillips JK, and Sandow SL. Heterogeneous control of blood flow amongst different vascular beds. Med Res Rev 21: 1-60, 2001.
31. Horibe M, Ogawa K, Sohn JT, and Murray PA. Propofol attenuates acetylcholine-induced pulmonary vasorelaxation: role of nitric oxide and endothelium-derived hyperpolarizing factors. Anesthesiology 93: 447-455, 2000.
32. + release in isolated renal arteries of rats. Br J Pharmacol 132: 1558-1564, 2001.
33. Jiang F, Li CG, and Rand MJ. Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries. Br J Pharmacol 130: 1191-1200, 2000.
34. Karamsetty MR, Nakashima JM, Ou L, Klinger JR, and Hill NS. EDHF contributes to strain-related differences in pulmonary arterial relaxation in rats. Am J Physiol Lung Cell Mol Physiol 280: L458-L464, 2001.
35. 2+ entry in in situ endothelial cells of the porcine aortic valve and the endothelium-dependent relaxation in the porcine coronary artery. Br J Pharmacol 131: 115-123, 2000.
36. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
37. 2+ release from ryanodine-sensitive store contributes to mechanism of hypoxic vasoconstriction in rat lungs. J Appl Physiol 92: 527-534, 2002.
38. Muramatsu M, Rodman DM, Oka M, and McMurtry IF. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs. Am J Physiol Lung Cell Mol Physiol 272: L807-L812, 1997.
39. Muramatsu M, Tyler RC, Rodman DM, and McMurtry IF. Thapsigargin stimulates increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries. J Appl Physiol 80: 1336-1344, 1996.
40. Ogawa K, Tanaka S, and Murray PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 94: 668-677, 2001.
41. Oka M, Hasunuma K, Webb SA, Stelzner TJ, Rodman DM, and McMurtry IF. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am J Physiol Lung Cell Mol Physiol 264: L587-L597, 1993.
42. Petersson J, Zygmunt PM, Jonsson P, and Hogestatt ED. Characterization of endothelium-dependent relaxation in guinea pig basilar artery-effect of hypoxia and role of cytochrome P450 mono-oxygenase. J Vasc Res 35: 285-294, 1998.
43. Popp R, Brandes RP, Ott G, Busse R, and Fleming I. Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res 90: 800-806, 2002.
44. Pratt PF, Li P, Hillard CJ, Kurian J, and Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 280: H1113-H1121, 2001.
45. Quilley J and McGiff JC. Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21: 121-124, 2000.
46. Sandow SL and Hill CE. Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ Res 86: 341-346, 2000.
47. Sandow SL, Tare M, Coleman HA, Hill CE, and Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res 90: 1108-1113, 2002.
48. Schuster A, Oishi H, Beny JL, Stergiopulos N, and Meister JJ. Simultaneous arterial calcium dynamics and diameter measurements: application to myoendothelial communication. Am J Physiol Heart Circ Physiol 280: H1088-H1096, 2001.
49. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, and Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711, 1996.
50. Tanaka Y, Otsuka A, Tanaka H, and Shigenobu K. Glycyrrhetinic acid-sensitive mechanism does not make a major contribution to non-prostanoid, non-nitric oxide mediated endothelium-dependent relaxation of rat mesenteric artery in response to acetylcholine. Res Commun Mol Pathol Pharmacol 103: 227-239, 1999.
51. Tare M, Coleman HA, and Parkington HC. Glycyrrhetinic derivatives inhibit hyperpolarization in endothelial cells of guinea pig and rat arteries. Am J Physiol Heart Circ Physiol 282: H335-H341, 2002.
52. Taylor HJ, Chaytor AT, Edwards DH, and Griffith TM. Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries. Biochem Biophys Res Commun 283: 583-589, 2001.
53. Taylor HJ, Chaytor AT, Evans WH, and Griffith TM. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid. Br J Pharmacol 125: 1-3, 1998.
54. Torok J. Histamine-induced relaxation in pulmonary artery of normotensive and hypertensive rats: relative contribution of prostanoids, nitric oxide and hyperpolarization. Physiol Res 49: 107-114, 2000.
55. Triggle CR and Ding H. Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator? Clin Exp Pharmacol Physiol 29: 153-160, 2002.
56. Ca channels and elicit EDHF-type arteriolar dilation via gap junctions. Am J Physiol Heart Circ Physiol 282: H1760-H1767, 2002.
57. van Kempen MJ and Jongsma HJ. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 112: 479-486, 1999.
58. Vanheel B and Van de Voorde J. Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery. J Physiol 501: 331-341, 1997.
59. Zhu D, Birks EK, Dawson CA, Patel M, Falck JR, Presberg K, Roman RJ, and Jacobs ER. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am J Physiol Heart Circ Physiol 279: H1526-H1533, 2000.